Lupin Secures CDSCO Panel Clearance for Phase III COPD Inhaler Trial
- 19 September 2025
- 1 month ago
Lupin Secures CDSCO Panel Nod for Phase IV Trial of Budesonide-Based COPD Inhaler
- 19 September 2025
- 1 month ago
Lupin bags USFDA approval for Multiple myeloma treatment
- 17 September 2025
- 1 month ago
Lupin gets 6 USFDA observations for Nagpur facility
- 17 September 2025
- 1 month ago
Lupin Manufacturing Solutions: Empagliflozin API gets CADIFA approval from ANVISA, Brazil
- 15 September 2025
- 1 month ago
Lupin Type 2 Diabetes Drug Canagliflozin Bags USFDA Tentative Approval
- 28 July 2025
- 3 months ago
Recent News
Himachal notifies Resident doctor policy 2025
- 02 November, 2025
Pfizer files lawsuit against Metsera, its Director...
- 02 November, 2025
Health Ministry achieves 3 Guinness World Records...
- 02 November, 2025
Roche gets CE mark for Elecsys Dengue Ag test to d...
- 02 November, 2025
Aadhaar authentication voluntary for NBE exams, cl...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.






